What is the Fiscal Year for Replimune Group?
Date: November 14, 2026
Replimune Group's current fiscal year starts on April 1, 2026, and ends on March 31, 2027. Their current quarter is Q3, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
April 1, 2026
Fiscal Year End
March 31, 2027
Current Quarter
Q3
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Apr 1, 2026 – Jun 30, 2026
Q2
Jul 1, 2026 – Sep 30, 2026
Q3
Oct 1, 2026 – Dec 31, 2026
Q4
Jan 1, 2027 – Mar 31, 2027
Company Information
Headquarters
Woburn, MA
Industry
Biotechnology Research
Stock Symbol
REPL
Website
http://www.replimune.comDescription
Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Replimune Group and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.